Procedure for use of Signaling Multiplex Panels 1-3
BRD ID: 3,027
Source: DCTD Tier: SOP Number of times downloaded: 15
Description
This document describes the procedures for the quantification of analytes by multiplex immunoassays, specifically the Luminex platform in conjunction with Total and Phospho AKT/rpS6 Panels, for pharmacodynamic studies. It is a product of the National Cancer Institute's (NCI) Division of Cancer Treatment and Diagnosis (DCTD). Visit the DCTD website (https://dctd.cancer.gov/ResearchResources/ResearchResources-biomarkers.htm) for recent updates to the SOP.
Documents for Download
SOP341404_LHTP_Signaling_Multiplex_AKT_rpS6_TTH_A.pdf [Size: 2003 KB]Biospecimens
- Tissue - Not specified
Diagnoses
- Neoplastic - Not specified
Topics
- Platform-specific Methodology
Associated SOP Compendiums
- Platform-specific Methodology